Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

J Paul Clancy


  • Director at Incyte Corp (INCY), 2020-01-03
  • Evp, Chief Financial Officer at Alexion Pharmaceuticals Inc. (ALXN), 2019-07-15
  • Director at Agios Pharmaceuticals Inc (AGIO), 2019-05-31
  • Executive Vp And Cfo at Biogen Inc. (BIIB), 2017-04-27
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ALXN $131.11 5,241 Officer 93,309 2018-07-10 Filing
ALXN $116.31 6,079 Officer 89,014 2018-02-08 Filing
BIIB $290.00 9,892 Officer 10,813 2017-04-25 Filing
BIIB $291.55 9,891 Officer 20,705 2017-03-13 Filing
BIIB $245.00 26,785 Officer 7,087 2013-09-18 Filing